ROYAL BANK OF CANADA - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 75 filers reported holding NOVELION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$04470.0%0.00%
Q2 2019$0
-100.0%
447
-32.2%
0.00%
Q1 2019$1,000659
+34.5%
0.00%
Q4 2018$0
-100.0%
490
+11.6%
0.00%
Q3 2018$1,000
-50.0%
439
-31.6%
0.00%
Q2 2018$2,000
+100.0%
642
+21.8%
0.00%
Q1 2018$1,000527
+101.1%
0.00%
Q4 2017$0
-100.0%
262
-82.5%
0.00%
Q3 2017$11,000
+450.0%
1,496
+484.4%
0.00%
Q2 2017$2,000
-33.3%
256
-20.7%
0.00%
Q1 2017$3,000
+50.0%
323
+36.9%
0.00%
Q4 2016$2,0002360.00%
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q2 2017.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders